Shypd.aiThe largest open index of AI toolsEarlyDiagnostics offers accurate, affordable, and non-invasive liquid biopsy tests for early cancer detection and precision medicine. It leverages cfDNA-based technologies and AI algorithms to provide solutions like CancerRadar and EarlyDx-Cloud.
Trending
Also listed in
About
EarlyDiagnostics (EarlyDx) is dedicated to advancing cancer detection and precision medicine through its innovative liquid biopsy tests. The company has developed CancerRadar, a highly accurate and sensitive blood test for detecting and locating cancer. Additionally, EarlyDx offers EarlyDx-Cloud, a comprehensive bioinformatics solution designed to assist diagnostic companies in offering liquid biopsy tests for cancer detection, therapy selection, and treatment monitoring. Their core technologies include cfMethyl-seq for profiling cfDNA methylome, cfSNV for accurately calling mutations from blood, and cfTrack for non-invasive monitoring of cancer MRD, recurrence, and evolution. EarlyDx aims to provide accessible and reliable tools for early disease diagnostics.
Capabilities
Pricing & Plans
Likely Not Free
Not publicly disclosed. Check earlydx.com for current pricing.
FAQs
Trending
